LivaNova PLC (LIA.F)

57,50 -1,50 (-2,54%) Ab 08:02AM CEST. Markt geöffnet.

LivaNova PLC

20 Eastbourne Terrace
London W2 6LG
United Kingdom
44 20 3325 0660
https://www.livanova.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 2.900

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Alex Shvartsburg	Chief Financial Officer	1,12M	N/A	1971
Mr. Michael D. Hutchinson	Senior VP, Chief Legal Officer & Company Secretary	1,02M	N/A	1971
Ms. Trui Hebbelinck	Chief Human Resources Officer	832,02k	N/A	1973
Mr. Vladimir A. Makatsaria	CEO & Director	N/A	N/A	1973
Mr. Badri Amurthur	Chief Technology Officer	N/A	N/A	N/A
Lindsey Little	Senior Director of Investor Relations	N/A	N/A	N/A
Deanna Wilke	Vice President of Corporate Communications	N/A	N/A	N/A
Mr. Matthew Joseph Dodds III	Senior Vice President of Corporate Development & IT	N/A	N/A	N/A
Dr. Bryan D. Olin Ph.D.	Senior VP & Head of Product Development - Neuromodulation	N/A	N/A	1967
Mr. Ryan Miller	President of Advanced Circulatory Support	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Corporate Governance

LivaNova PLCs ISS Governance QualityScore, Stand 1. Mai 2024, lautet 2. Die grundlegenden Scores sind Audit: 6, Vorstand: 1, Shareholderrechte: 3, Kompensation: 4.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.